These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. ATP-binding cassette transporter AI and its role in HDL formation. Lee JY; Parks JS Curr Opin Lipidol; 2005 Feb; 16(1):19-25. PubMed ID: 15650559 [TBL] [Abstract][Full Text] [Related]
9. Adiponectin's mechanisms in high-density lipoprotein biogenesis and cholesterol efflux. Hafiane A; Daskalopoulou SS Metabolism; 2020 Dec; 113():154393. PubMed ID: 33058851 [TBL] [Abstract][Full Text] [Related]
10. Identification of Docetaxel as a Potential Drug to Promote HDL Biogenesis. Choi HY; Ruel I; Genest J Front Pharmacol; 2021; 12():679456. PubMed ID: 34093205 [No Abstract] [Full Text] [Related]
11. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. Zannis VI; Chroni A; Krieger M J Mol Med (Berl); 2006 Apr; 84(4):276-94. PubMed ID: 16501936 [TBL] [Abstract][Full Text] [Related]
12. Docetaxel as a Model Compound to Promote HDL (High-Density Lipoprotein) Biogenesis and Reduce Atherosclerosis. Choi HY; Iatan I; Ruel I; Brown L; Hales L; Choi S; Genest J Arterioscler Thromb Vasc Biol; 2023 May; 43(5):609-617. PubMed ID: 36861478 [TBL] [Abstract][Full Text] [Related]
13. ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells. Choi HY; Rahmani M; Wong BW; Allahverdian S; McManus BM; Pickering JG; Chan T; Francis GA Circulation; 2009 Jun; 119(25):3223-31. PubMed ID: 19528336 [TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of ABCA1-dependent compartmentalization and trafficking of apolipoprotein A-I: implications for determining cellular kinetics of nascent high density lipoprotein biogenesis. Hassan HH; Bailey D; Lee DY; Iatan I; Hafiane A; Ruel I; Krimbou L; Genest J J Biol Chem; 2008 Apr; 283(17):11164-75. PubMed ID: 18218626 [TBL] [Abstract][Full Text] [Related]
17. Significance of the hydrophobic residues 225-230 of apoA-I for the biogenesis of HDL. Fotakis P; Tiniakou I; Kateifides AK; Gkolfinopoulou C; Chroni A; Stratikos E; Zannis VI; Kardassis D J Lipid Res; 2013 Dec; 54(12):3293-302. PubMed ID: 24123812 [TBL] [Abstract][Full Text] [Related]
18. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT. Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726 [TBL] [Abstract][Full Text] [Related]
19. The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo. Chroni A; Koukos G; Duka A; Zannis VI Biochemistry; 2007 May; 46(19):5697-708. PubMed ID: 17447731 [TBL] [Abstract][Full Text] [Related]
20. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. Kypreos KE; Zannis VI Biochem J; 2007 Apr; 403(2):359-67. PubMed ID: 17206937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]